A citation-based method for searching scientific literature

Irina Larionova, Nadezhda Cherdyntseva, Tengfei Liu, Marina Patysheva, Militsa Rakina, Julia Kzhyshkowska. Oncoimmunology 2019
Times Cited: 123







List of co-cited articles
1045 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
22

Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy, Jeffrey W Pollard. Immunity 2014
18


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
14

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
13

Microenvironmental regulation of tumor progression and metastasis.
Daniela F Quail, Johanna A Joyce. Nat Med 2013
12

Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.
Vladimir Riabov, Alexandru Gudima, Nan Wang, Amanda Mickley, Alexander Orekhov, Julia Kzhyshkowska. Front Physiol 2014
345
11

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.
Luca Cassetta, Stamatina Fragkogianni, Andrew H Sims, Agnieszka Swierczak, Lesley M Forrester, Hui Zhang, Daniel Y H Soong, Tiziana Cotechini, Pavana Anur, Elaine Y Lin,[...]. Cancer Cell 2019
349
11

Macrophages as regulators of tumour immunity and immunotherapy.
David G DeNardo, Brian Ruffell. Nat Rev Immunol 2019
649
10


CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro,[...]. Nat Med 2013
10

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
Alberto Mantovani, Silvano Sozzani, Massimo Locati, Paola Allavena, Antonio Sica. Trends Immunol 2002
9


Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Michael A Cannarile, Martin Weisser, Wolfgang Jacob, Anna-Maria Jegg, Carola H Ries, Dominik Rüttinger. J Immunother Cancer 2017
463
9


Macrophages and therapeutic resistance in cancer.
Brian Ruffell, Lisa M Coussens. Cancer Cell 2015
791
8

The chemokine system in diverse forms of macrophage activation and polarization.
Alberto Mantovani, Antonio Sica, Silvano Sozzani, Paola Allavena, Annunciata Vecchi, Massimo Locati. Trends Immunol 2004
8

Targeting Tumor-Associated Macrophages in Cancer.
Paulina Pathria, Tiani L Louis, Judith A Varner. Trends Immunol 2019
387
8


PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
944
8

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Carlos W Wanderley, David F Colón, João Paulo M Luiz, Francisco F Oliveira, Paula R Viacava, Caio A Leite, Janaina A Pereira, Camila M Silva, Cassia R Silva, Rangel L Silva,[...]. Cancer Res 2018
181
8

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
David G DeNardo, Donal J Brennan, Elton Rexhepaj, Brian Ruffell, Stephen L Shiao, Stephen F Madden, William M Gallagher, Nikhil Wadhwani, Scott D Keil, Sharfaa A Junaid,[...]. Cancer Discov 2011
7

Role of macrophage targeting in the antitumor activity of trabectedin.
Giovanni Germano, Roberta Frapolli, Cristina Belgiovine, Achille Anselmo, Samantha Pesce, Manuela Liguori, Eugenio Erba, Sarah Uboldi, Massimo Zucchetti, Fabio Pasqualini,[...]. Cancer Cell 2013
545
7

Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment.
Eveline M Dijkgraaf, Moniek Heusinkveld, Bart Tummers, Lisa T C Vogelpoel, Renske Goedemans, Veena Jha, Johan W R Nortier, Marij J P Welters, Judith R Kroep, Sjoerd H van der Burg. Cancer Res 2013
211
7

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Carola H Ries, Michael A Cannarile, Sabine Hoves, Jörg Benz, Katharina Wartha, Valeria Runza, Flora Rey-Giraud, Leon P Pradel, Friedrich Feuerhake, Irina Klaman,[...]. Cancer Cell 2014
800
7

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Marcus Noel, Eileen M O'Reilly, Brian M Wolpin, David P Ryan, Andrea J Bullock, Carolyn D Britten, David C Linehan, Brian A Belt, Eric C Gamelin, Bishu Ganguly,[...]. Invest New Drugs 2020
60
11

Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Xiaolan Zhu, Huiling Shen, Xinming Yin, Meiling Yang, Hong Wei, Qi Chen, Fan Feng, Yueqin Liu, Wenlin Xu, Yuefeng Li. J Exp Clin Cancer Res 2019
160
7

Targeting macrophages: therapeutic approaches in cancer.
Luca Cassetta, Jeffrey W Pollard. Nat Rev Drug Discov 2018
668
7

Tumor-associated macrophages: an accomplice in solid tumor progression.
Yibing Chen, Yucen Song, Wei Du, Longlong Gong, Haocai Chang, Zhengzhi Zou. J Biomed Sci 2019
300
7

Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.
Clément Anfray, Aldo Ummarino, Fernando Torres Andón, Paola Allavena. Cells 2019
103
7

Exploring the full spectrum of macrophage activation.
David M Mosser, Justin P Edwards. Nat Rev Immunol 2008
7

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Timothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, Brian A Belt, Roheena Z Panni, Brian M Cusworth, Adetunji T Toriola, Rebecca K Nieman, Lori A Worley, Motoyo Yano,[...]. Lancet Oncol 2016
404
6

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.
F Zhang, N N Parayath, C I Ene, S B Stephan, A L Koehne, M E Coon, E C Holland, M T Stephan. Nat Commun 2019
156
6

Macrophage plasticity and polarization: in vivo veritas.
Antonio Sica, Alberto Mantovani. J Clin Invest 2012
6

Macrophage biology in development, homeostasis and disease.
Thomas A Wynn, Ajay Chawla, Jeffrey W Pollard. Nature 2013
6

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors.
Kyriakos P Papadopoulos, Larry Gluck, Lainie P Martin, Anthony J Olszanski, Anthony W Tolcher, Gataree Ngarmchamnanrith, Erik Rasmussen, Benny M Amore, Dirk Nagorsen, John S Hill,[...]. Clin Cancer Res 2017
109
6

Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.
Tanaya Shree, Oakley C Olson, Benelita T Elie, Jemila C Kester, Alfred L Garfall, Kenishana Simpson, Katherine M Bell-McGuinn, Emily C Zabor, Edi Brogi, Johanna A Joyce. Genes Dev 2011
360
6

Macrophage regulation of tumor responses to anticancer therapies.
Michele De Palma, Claire E Lewis. Cancer Cell 2013
703
6


Immunity, inflammation, and cancer.
Sergei I Grivennikov, Florian R Greten, Michael Karin. Cell 2010
6

Turning foes to friends: targeting cancer-associated fibroblasts.
Xueman Chen, Erwei Song. Nat Rev Drug Discov 2019
578
6

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.
G Solinas, G Germano, A Mantovani, P Allavena. J Leukoc Biol 2009
961
6

Tumor-associated macrophages as major players in the tumor microenvironment.
Theerawut Chanmee, Pawared Ontong, Kenjiro Konno, Naoki Itano. Cancers (Basel) 2014
882
6

Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice.
Sharmilla Devi Jayasingam, Marimuthu Citartan, Thean Hock Thang, Anani Aila Mat Zin, Kai Cheen Ang, Ewe Seng Ch'ng. Front Oncol 2020
199
6

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Stephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, Debashis Sahoo, Piero Dalerba, Siddhartha S Mitra, Jian Wang, Humberto Contreras-Trujillo, Robin Martin, Justin D Cohen,[...]. Proc Natl Acad Sci U S A 2012
862
6

Tumor microenvironment complexity and therapeutic implications at a glance.
Roghayyeh Baghban, Leila Roshangar, Rana Jahanban-Esfahlan, Khaled Seidi, Abbas Ebrahimi-Kalan, Mehdi Jaymand, Saeed Kolahian, Tahereh Javaheri, Peyman Zare. Cell Commun Signal 2020
309
6

Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.
Irina Larionova, Gulnara Tuguzbaeva, Anastasia Ponomaryova, Marina Stakheyeva, Nadezhda Cherdyntseva, Valentin Pavlov, Evgeniy Choinzonov, Julia Kzhyshkowska. Front Oncol 2020
87
6

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
6

Targeting tumor-associated macrophages to synergize tumor immunotherapy.
Xiaonan Xiang, Jianguo Wang, Di Lu, Xiao Xu. Signal Transduct Target Ther 2021
91
6



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.